Breast Cancer: Biomarkers of Diagnosis and Prognosis

Dear Colleagues,

Breast cancer is a complex disease with high incidence rates worldwide; moreover, it has the second highest mortality in women out of all cancers and therefore remains a key global clinical challenge. However, it exhibits significant clinical and biological heterogeneity with divergent patient outcomes. Diagnostic and prognostic biomarkers are fundamental in the clinical pathway for treating breast cancer and hold great promise for personalized medicine. These can range from imaging-, tissue-, to serological-based markers.

Currently, only a few biomarkers remain decisive. This Special Issue aims to highlight key emerging biomarkers for early detection, predicting recurrence, metastatic spread, and treatment response. By exploring this diverse landscape of biomarkers, we hope to gain a deeper understanding of breast cancer heterogeneity and ultimately pave the way for personalized treatment approaches for every patient.

Dr. Andrew R. Green
Dr. Sarah J. Storr
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• breast cancer
• biomarker
• diagnosis
• prognosis